Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Oct;74(4):1307–1317. doi: 10.1172/JCI111541

Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

G Birnbaum, L Kotilinek, M Schwartz, M Sternad
PMCID: PMC425298  PMID: 6237121

Abstract

Spinal fluid lymphocytes from multiple sclerosis (MS) patients and controls were stimulated with either autologous non-T cells or with allogeneic non-T cells followed by stimulation with autologous non-T lymphocytes. Cells responding to these stimuli were cloned and their proliferative responses to autologous and allogeneic MS and normal non-T cells were measured. Large numbers of clones with specific patterns of reaction to both autologous and allogeneic cells were obtained from lymphocytes in MS cerebrospinal fluid (CSF), but only occasionally from cells in control CSF. Patterns of responses among clones from a particular CSF were similar and often identical, which suggested that cells in MS CSF were relatively restricted in their specificities. Surface antigen phenotyping of the clones showed them to be predominantly OKT4+, with 13% OKT8+ and 11% OKT4+8+. Peripheral T cells that were stimulated and cultured in parallel with CSF cells were different in that they usually did not give rise to as many clones nor were their patterns of response similar. Many CSF clones were heteroclitic, that is they responded to particular allogeneic cells but not autologous cells. Lymphocytes in MS CSF thus appear to represent a selected population of cells with a high frequency of responsiveness to autologous and allogeneic antigens. Such responses may be evidence for immune regulation within the central nervous system or could represent responses to altered-self antigens.

Full text

PDF
1307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abromson-Leeman S. R., Cantor H. Specificity of T cell clones for antigen and autologous major histocompatibility complex products determines specificity for foreign major histocompatibility complex products. J Exp Med. 1983 Aug 1;158(2):428–437. doi: 10.1084/jem.158.2.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen J. C., Sheremata W., Cosgrove J. B., Osterland K., Shea M. Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis. Neurology. 1976 Jun;26(6 Pt 1):579–583. doi: 10.1212/wnl.26.6.579. [DOI] [PubMed] [Google Scholar]
  3. Alter M. Multiple sclerosis, herpes viruses, and immunity. Lancet. 1981 Nov 28;2(8257):1224–1225. doi: 10.1016/s0140-6736(81)91455-0. [DOI] [PubMed] [Google Scholar]
  4. Antel J. P., Richman D. P., Medof M. E., Arnason B. G. Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology. 1978 Sep;28(9 Pt 2):106–110. doi: 10.1212/wnl.28.9_part_2.106. [DOI] [PubMed] [Google Scholar]
  5. Bach F. H., Alter B. J., Widmer M. B., Segall M., Dunlap B. Cloned cytotoxic and non-cytotoxic lymphocytes in mouse and man: their reactivities and a large cell surface membrane protein (LMP) differentiation marker system. Immunol Rev. 1981;54:5–26. doi: 10.1111/j.1600-065x.1981.tb00432.x. [DOI] [PubMed] [Google Scholar]
  6. Bevan M. J. Killer cells reactive to altered-self antigens can also be alloreactive. Proc Natl Acad Sci U S A. 1977 May;74(5):2094–2098. doi: 10.1073/pnas.74.5.2094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Birnbaum G., Kotilinek L. Autologous lymphocyte proliferation in multiple sclerosis and the effect of intravenous ACTH. Ann Neurol. 1981 May;9(5):439–446. doi: 10.1002/ana.410090505. [DOI] [PubMed] [Google Scholar]
  8. Burns J. B., Zweiman B., Lisak R. P. Long-term growth in vitro of human cerebrospinal fluid T lymphocytes. J Clin Immunol. 1981 Jul;1(3):195–200. doi: 10.1007/BF00922763. [DOI] [PubMed] [Google Scholar]
  9. Cahill G. F., Jr, McDevitt H. O. Insulin-dependent diabetes mellitus: the initial lesion. N Engl J Med. 1981 Jun 11;304(24):1454–1465. doi: 10.1056/NEJM198106113042403. [DOI] [PubMed] [Google Scholar]
  10. Cashman N., Martin C., Eizenbaum J. F., Degos J. D., Bach M. A. Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid. J Clin Invest. 1982 Aug;70(2):387–392. doi: 10.1172/JCI110628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cook S. D., Dowling P. C. Multiple sclerosis and viruses: an overview. Neurology. 1980 Jul;30(7 Pt 2):80–91. doi: 10.1212/wnl.30.7_part_2.80. [DOI] [PubMed] [Google Scholar]
  12. Damle N. K., Gupta S. Autologous mixed lymphocyte reaction in man. V. Functionally and phenotypically distinct human T-cell subpopulations respond to non-T and activated T cells in AMLR. Scand J Immunol. 1982 Jul;16(1):59–68. doi: 10.1111/j.1365-3083.1982.tb00699.x. [DOI] [PubMed] [Google Scholar]
  13. Engleman E. G., McMichael A. J., Batey M. E., McDevitt H. O. A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J Exp Med. 1978 Jan 1;147(1):137–146. doi: 10.1084/jem.147.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fleischer B., Kreth H. W. Clonal analysis of HLA-restricted virus-specific cytotoxic T lymphocytes from cerebrospinal fluid in mumps meningitis. J Immunol. 1983 May;130(5):2187–2190. [PubMed] [Google Scholar]
  15. Gaston J. S., Rickinson A. B., Epstein M. A. Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants. J Exp Med. 1983 Dec 1;158(6):1804–1821. doi: 10.1084/jem.158.6.1804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Goust J. M., Hogan E. L., Arnaud P. Abnormal regulation of IgG production in multiple sclerosis. Neurology. 1982 Mar;32(3):228–234. doi: 10.1212/wnl.32.3.228. [DOI] [PubMed] [Google Scholar]
  17. Hauser S. L., Reinherz E. L., Hoban C. J., Schlossman S. F., Weiner H. L. CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell subsets. Neurology. 1983 May;33(5):575–579. doi: 10.1212/wnl.33.5.575. [DOI] [PubMed] [Google Scholar]
  18. Hausman P. B., Stobo J. D. Specificity and function of a human autologous reactive T cell. J Exp Med. 1979 Jun 1;149(6):1537–1542. doi: 10.1084/jem.149.6.1537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hirschberg H., Thorsby E. Activation of human suppressor cells in mixed lymphocyte cultures. Scand J Immunol. 1977;6(8):809–815. doi: 10.1111/j.1365-3083.1977.tb02154.x. [DOI] [PubMed] [Google Scholar]
  20. Ho H. Z., Tiwari J. L., Haile R. W., Terasaki P. I., Morton N. E. HLA-linked and unlinked determinants of multiple sclerosis. Immunogenetics. 1982;15(5):509–517. doi: 10.1007/BF00345910. [DOI] [PubMed] [Google Scholar]
  21. Horta-Barbosa L., Hamilton R., Wittig B., Fuccillo D. A., Sever J. L., Vernon M. L. Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies. Science. 1971 Aug 27;173(3999):840–841. doi: 10.1126/science.173.3999.840. [DOI] [PubMed] [Google Scholar]
  22. Inouye H., Hank J. A., Alter B. J., Bach F. H. TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol. 1980;12(2):149–154. doi: 10.1111/j.1365-3083.1980.tb00051.x. [DOI] [PubMed] [Google Scholar]
  23. Kam-Hansen S., Andersson R., Link H. Cerebrospinal fluid lymphocytes from patients with multiple sclerosis and aseptic meningo-encephalitis respond in mixed lymphocyte culture. J Neuroimmunol. 1983 Aug;5(1):67–81. doi: 10.1016/0165-5728(83)90027-9. [DOI] [PubMed] [Google Scholar]
  24. Kam-Hansen S. Distribution and function of lymphocytes from the cerebrospinal from the cerebrospinal fluid and blood in patients with multiple sclerosis. Acta Neurol Scand Suppl. 1980;75:1–81. [PubMed] [Google Scholar]
  25. Kam-Hansen S., Link H., Fryden A., Möller E. Reduced in vitro response of CSF lymphocytes to mitogen stimulation in multiple sclerosis. Scand J Immunol. 1979;10(2):161–169. doi: 10.1111/j.1365-3083.1979.tb03271.x. [DOI] [PubMed] [Google Scholar]
  26. Kozak R. W., Moody C. E., Staiano-Coico L., Weksler M. E. Lymphocyte transformation induced by autologous cells. XII. Quantitative and qualitative differences between human autologous and allogeneic reactive T lymphocytes. J Immunol. 1982 Apr;128(4):1723–1727. [PubMed] [Google Scholar]
  27. Levinson A. I., Lisak R. P., Zweiman B. Immunologic characterization of cerebrospinal fluid lymphocytes: preliminary report. Neurology. 1976 Jul;26(7):693–695. doi: 10.1212/wnl.26.7.693. [DOI] [PubMed] [Google Scholar]
  28. Levitt D., Griffin N. B., Egan M. L. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis. J Immunol. 1980 May;124(5):2117–2121. [PubMed] [Google Scholar]
  29. Link H., Müller R. Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol. 1971 Oct;25(4):326–344. doi: 10.1001/archneur.1971.00490040052007. [DOI] [PubMed] [Google Scholar]
  30. Lisak R. P., Zweiman B. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases. N Engl J Med. 1977 Oct 20;297(16):850–853. doi: 10.1056/NEJM197710202971602. [DOI] [PubMed] [Google Scholar]
  31. Martin J. R. Herpes simplex virus types 1 and 2 and multiple sclerosis. Lancet. 1981 Oct 10;2(8250):777–781. doi: 10.1016/s0140-6736(81)90188-4. [DOI] [PubMed] [Google Scholar]
  32. McFarland H. F., McFarlin D. E. Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis. Ann Neurol. 1979 Aug;6(2):101–106. doi: 10.1002/ana.410060204. [DOI] [PubMed] [Google Scholar]
  33. Merrill J. E., Biberfeld G., Landin S., Sidén A., Norrby E. Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients. Clin Exp Immunol. 1980 Nov;42(2):345–354. [PMC free article] [PubMed] [Google Scholar]
  34. Merrill J. E., Gerner R. H., Myers L. W., Ellison G. W. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferon. J Neuroimmunol. 1983 Jun;4(3):223–237. doi: 10.1016/0165-5728(83)90037-1. [DOI] [PubMed] [Google Scholar]
  35. Meuer S. C., Schlossman S. F., Reinherz E. L. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4395–4399. doi: 10.1073/pnas.79.14.4395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Narayan O., Griffin D. E., Clements J. E. Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol. 1978 Nov;41(2):343–352. doi: 10.1099/0022-1317-41-2-343. [DOI] [PubMed] [Google Scholar]
  37. Noronha A. B., Richman D. P., Arnason B. G. Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis. N Engl J Med. 1980 Sep 25;303(13):713–717. doi: 10.1056/NEJM198009253031301. [DOI] [PubMed] [Google Scholar]
  38. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  39. Prineas J. W., Wright R. G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest. 1978 Apr;38(4):409–421. [PubMed] [Google Scholar]
  40. Reder A., Birnbaum G. B-cell differentiation in multiple sclerosis and the effect of intravenous ACTH. Neurology. 1983 Apr;33(4):442–446. doi: 10.1212/wnl.33.4.442. [DOI] [PubMed] [Google Scholar]
  41. Reinherz E. L., Weiner H. L., Hauser S. L., Cohen J. A., Distaso J. A., Schlossman S. F. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med. 1980 Jul 17;303(3):125–129. doi: 10.1056/NEJM198007173030303. [DOI] [PubMed] [Google Scholar]
  42. Reunanen M., Salmi A., Ilonen J., Herva E. Proliferation of multiple sclerosis cerebrospinal fluid lymphocytes after stimulation with measles virus antigens. Acta Neurol Scand. 1980 Nov;62(5):293–299. doi: 10.1111/j.1600-0404.1980.tb03039.x. [DOI] [PubMed] [Google Scholar]
  43. Sasportes M., Wollman E., Cohen D., Carosella E., Bensussan A., Fradelizi D., Dausset J. Suppression of the human allogenetic response in vitro with primed lymphocytes and suppressive supernates. J Exp Med. 1980 Aug 1;152(2 Pt 2):270s–283s. [PubMed] [Google Scholar]
  44. Sheehy M. J., Mawas C., Charmot D. Specific inhibition of human lymphocyte responses by primed autologous lymphocytes. I. Evaluation of MLR inhibition as a model for suppression. J Immunol. 1979 Jun;122(6):2198–2203. [PubMed] [Google Scholar]
  45. Smith J. B., Knowlton R. P. Activation of suppressor T cells in human autologous mixed lymphocyte culture. J Immunol. 1979 Jul;123(1):419–422. [PubMed] [Google Scholar]
  46. Sredni B., Schwartz R. H. Alloreactivity of an antigen-specific T-cell clone. Nature. 1980 Oct 30;287(5785):855–857. doi: 10.1038/287855a0. [DOI] [PubMed] [Google Scholar]
  47. Traugott U., Reinherz E. L., Raine C. S. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science. 1983 Jan 21;219(4582):308–310. doi: 10.1126/science.6217550. [DOI] [PubMed] [Google Scholar]
  48. Ukkonen P., Granström M. L., Räsänen J., Salonen E. M., Penttinen K. Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients. J Med Virol. 1981;8(4):257–265. doi: 10.1002/jmv.1890080406. [DOI] [PubMed] [Google Scholar]
  49. Wee S. L., Chen L. K., Strassmann G., Bach F. H. Helper cell-independent cytotoxic clones in man. J Exp Med. 1982 Dec 1;156(6):1854–1859. doi: 10.1084/jem.156.6.1854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zinkernagel R. M., Doherty P. C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974 Apr 19;248(5450):701–702. doi: 10.1038/248701a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES